organization · Reporting owner
Pura Vida Master Fund, LTD
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MedMen Enterprises, Inc.
Report date August 17, 2021 · Filed April 29, 2022
Jointly reported with PURA VIDA INVESTMENTS, LLC, Kamen Efrem
Section 16 reporting ended · disclosed 2022-04-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.17 · Expires 2028-08-17 | IndirectBy Pura Vida Master Fund, LTD. | Not disclosed |
Reported balance
After 2021-08-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2028-08-17 | IndirectBy Pura Vida Master Fund, LTD. | Not disclosed |
Reported balance
After 2021-08-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.34 · Expires 2028-08-17 | IndirectBy Pura Vida Master Fund, LTD. | Not disclosed |
Reported balance
After 2021-08-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.28 · Expires 2028-08-17 | IndirectBy Pura Vida Master Fund, LTD. | Not disclosed |
Reported balance
After 2021-08-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.17 · Expires 2028-08-17 | IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD. | Not disclosed |
Reported balance
After 2021-08-17 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2028-08-17 | IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD. | Not disclosed |
Reported balance
After 2021-08-17 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.34 · Expires 2028-08-17 | IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD. | Not disclosed |
Reported balance
After 2021-08-17 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.28 · Expires 2028-08-17 | IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD. | Not disclosed |
Reported balance
After 2021-08-17 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.72 · Expires 2022-05-22 | IndirectBy Pura Vida Master Fund, LTD. | 234,753 |
Reported balance
After 2021-08-17 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-08-17 · Other · Disposed 435,971 · Balance 234,753 F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $4.29 · Expires 2022-05-22 | IndirectBy Pura Vida Master Fund, LTD. | 67,818 |
Reported balance
After 2021-08-17 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2021-08-17 · Other · Disposed 125,947 · Balance 67,818 F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.16 · Expires 2022-07-12 | IndirectBy Pura Vida Master Fund, LTD. | 69,074 |
Reported balance
After 2021-08-17 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2021-08-17 · Other · Disposed 128,279 · Balance 69,074 F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.65 · Expires 2022-07-12 | IndirectBy Pura Vida Master Fund, LTD. | 19,955 |
Reported balance
After 2021-08-17 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2021-08-17 · Other · Disposed 37,058 · Balance 19,955 F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.01 · Expires 2022-11-27 | IndirectBy Pura Vida Master Fund, LTD. | 86,322 |
Reported balance
After 2021-08-17 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2021-08-17 · Other · Disposed 160,311 · Balance 86,322 F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.17 · Expires 2022-11-27 | IndirectBy Pura Vida Master Fund, LTD. | 24,938 |
Reported balance
After 2021-08-17 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2021-08-17 · Other · Disposed 46,313 · Balance 24,938 F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2025-03-27 | IndirectBy Pura Vida Master Fund, LTD. | 4,349,248 |
Reported balance
After 2021-08-17 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2021-08-17 · Other · Disposed 8,077,175 · Balance 4,349,248 F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.72 · Expires 2022-05-22 | IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD. | 74,132 |
Reported balance
After 2021-08-17 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2021-08-17 · Other · Disposed 137,675 · Balance 74,132 F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $4.29 · Expires 2022-05-22 | IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD. | 21,416 |
Reported balance
After 2021-08-17 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2021-08-17 · Other · Disposed 39,773 · Balance 21,416 F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.16 · Expires 2022-07-12 | IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD. | 21,813 |
Reported balance
After 2021-08-17 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2021-08-17 · Other · Disposed 40,509 · Balance 21,813 F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.65 · Expires 2022-07-12 | IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD. | 6,301 |
Reported balance
After 2021-08-17 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2021-08-17 · Other · Disposed 11,703 · Balance 6,301 F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.01 · Expires 2022-11-27 | IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD. | 27,259 |
Reported balance
After 2021-08-17 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2021-08-17 · Other · Disposed 50,625 · Balance 27,259 F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.17 · Expires 2022-11-27 | IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD. | 7,875 |
Reported balance
After 2021-08-17 transaction · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · 2021-08-17 · Other · Disposed 14,625 · Balance 7,875 F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2025-03-27 | IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD. | 1,373,447 |
Reported balance
After 2021-08-17 transaction · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · 2021-08-17 · Other · Disposed 2,550,687 · Balance 1,373,447 F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2: Currently exercisable. F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.
F2: Currently exercisable.
F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.
F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.
F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 2,550,687 | Not disclosed Strike: $0.15 | Not disclosed |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 22 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 1,373,447 Underlying: Class B Subordinate Voting Shares · 3,924,133 shares Expires 2025-03-27 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 14,625 | Not disclosed Strike: $1.17 | Not disclosed |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 21 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 7,875 Underlying: Class B Subordinate Voting Shares · 22,500 shares Expires 2022-11-27 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 50,625 | Not disclosed Strike: $1.01 | Not disclosed |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 20 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 27,259 Underlying: Class B Subordinate Voting Shares · 77,884 shares Expires 2022-11-27 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 11,703 | Not disclosed Strike: $3.65 | Not disclosed |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 19 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 6,301 Underlying: Class B Subordinate Voting Shares · 18,004 shares Expires 2022-07-12 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 40,509 | Not disclosed Strike: $3.16 | Not disclosed |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 18 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 21,813 Underlying: Class B Subordinate Voting Shares · 62,322 shares Expires 2022-07-12 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 39,773 | Not disclosed Strike: $4.29 | Not disclosed |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 17 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 21,416 Underlying: Class B Subordinate Voting Shares · 61,189 shares Expires 2022-05-22 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 137,675 | Not disclosed Strike: $3.72 | Not disclosed |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 16 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 74,132 Underlying: Class B Subordinate Voting Shares · 211,807 shares Expires 2022-05-22 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 8,077,175 | Not disclosed Strike: $0.15 | Not disclosed |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 15 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 4,349,248 Underlying: Class B Subordinate Voting Shares · 12,426,422 shares Expires 2025-03-27 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 46,313 | Not disclosed Strike: $1.17 | Not disclosed |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 14 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 24,938 Underlying: Class B Subordinate Voting Shares · 71,250 shares Expires 2022-11-27 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 160,311 | Not disclosed Strike: $1.01 | Not disclosed |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 13 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 86,322 Underlying: Class B Subordinate Voting Shares · 246,633 shares Expires 2022-11-27 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 37,058 | Not disclosed Strike: $3.65 | Not disclosed |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 12 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 19,955 Underlying: Class B Subordinate Voting Shares · 57,013 shares Expires 2022-07-12 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 128,279 | Not disclosed Strike: $3.16 | Not disclosed |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 11 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 69,074 Underlying: Class B Subordinate Voting Shares · 197,353 shares Expires 2022-07-12 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 125,947 | Not disclosed Strike: $4.29 | Not disclosed |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 10 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 67,818 Underlying: Class B Subordinate Voting Shares · 193,765 shares Expires 2022-05-22 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 435,971 | Not disclosed Strike: $3.72 | Not disclosed |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 9 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 234,753 Underlying: Class B Subordinate Voting Shares · 670,724 shares Expires 2022-05-22 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherSenior Secured Convertible Note · Derivative | Not disclosed | Not disclosed Strike: $0.28 | $50,567.99 |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 8 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: Not disclosed Underlying: Class B Subordinate Voting Shares · 236,991 shares Expires 2028-08-17 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherSenior Secured Convertible Note · Derivative | Not disclosed | Not disclosed Strike: $0.34 | $2,046,495.53 |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 7 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: Not disclosed Underlying: Class B Subordinate Voting Shares · 8,025,472 shares Expires 2028-08-17 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherSenior Secured Convertible Note · Derivative | Not disclosed | Not disclosed Strike: $0.15 | $1,503,749.88 |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 6 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: Not disclosed Underlying: Class B Subordinate Voting Shares · 13,113,144 shares Expires 2028-08-17 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherSenior Secured Convertible Note · Derivative | Not disclosed | Not disclosed Strike: $0.17 | $1,101,959.13 |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 5 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: Not disclosed Underlying: Class B Subordinate Voting Shares · 8,642,816 shares Expires 2028-08-17 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherSenior Secured Convertible Note · Derivative | Not disclosed | Not disclosed Strike: $0.28 | $160,131.97 |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 4 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: Not disclosed Underlying: Class B Subordinate Voting Shares · 750,472 shares Expires 2028-08-17 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherSenior Secured Convertible Note · Derivative | Not disclosed | Not disclosed Strike: $0.34 | $6,480,570.00 |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 3 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: Not disclosed Underlying: Class B Subordinate Voting Shares · 25,414,000 shares Expires 2028-08-17 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherSenior Secured Convertible Note · Derivative | Not disclosed | Not disclosed Strike: $0.15 | $4,761,875.18 |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 2 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: Not disclosed Underlying: Class B Subordinate Voting Shares · 41,524,963 shares Expires 2028-08-17 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| August 17, 2021 Filed Apr 29, 2022 20:45 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherSenior Secured Convertible Note · Derivative | Not disclosed | Not disclosed Strike: $0.17 | $3,489,537.69 |
DisclosureSEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 1 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: Not disclosed Underlying: Class B Subordinate Voting Shares · 27,368,923 shares Expires 2028-08-17 F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities. F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment. F2 · derivative.exercise_date: Currently exercisable. F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| April 21, 2021 Filed Apr 29, 2022 20:43 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 1,259,035 | Not disclosed Strike: $0.16 | Not disclosed |
DisclosureSEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 8 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 0 Underlying: Class B Subordinate Voting Shares · 1,259,035 shares Expires 2026-01-11 F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021. F2 · price: Not applicable. F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| April 21, 2021 Filed Apr 29, 2022 20:43 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 506,250 | Not disclosed Strike: $0.20 | Not disclosed |
DisclosureSEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 7 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 0 Underlying: Class B Subordinate Voting Shares · 506,250 shares Expires 2025-09-14 F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021. F2 · price: Not applicable. F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| April 21, 2021 Filed Apr 29, 2022 20:43 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 194,712 | Not disclosed Strike: $0.26 | Not disclosed |
DisclosureSEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 6 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 0 Underlying: Class B Subordinate Voting Shares · 194,712 shares Expires 2025-04-24 F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021. F2 · price: Not applicable. F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| April 21, 2021 Filed Apr 29, 2022 20:43 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 973,558 | Not disclosed Strike: $0.26 | Not disclosed |
DisclosureSEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 5 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 0 Underlying: Class B Subordinate Voting Shares · 973,558 shares Expires 2025-03-27 F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021. F2 · price: Not applicable. F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| April 21, 2021 Filed Apr 29, 2022 20:43 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 3,986,944 | Not disclosed Strike: $0.16 | Not disclosed |
DisclosureSEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 4 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 0 Underlying: Class B Subordinate Voting Shares · 3,986,944 shares Expires 2026-01-11 F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021. F2 · price: Not applicable. F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| April 21, 2021 Filed Apr 29, 2022 20:43 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 1,603,125 | Not disclosed Strike: $0.20 | Not disclosed |
DisclosureSEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 3 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 0 Underlying: Class B Subordinate Voting Shares · 1,603,125 shares Expires 2025-09-14 F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021. F2 · price: Not applicable. F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| April 21, 2021 Filed Apr 29, 2022 20:43 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 616,587 | Not disclosed Strike: $0.26 | Not disclosed |
DisclosureSEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 2 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 0 Underlying: Class B Subordinate Voting Shares · 616,587 shares Expires 2025-04-24 F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021. F2 · price: Not applicable. F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| April 21, 2021 Filed Apr 29, 2022 20:43 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 3,082,933 | Not disclosed Strike: $0.26 | Not disclosed |
DisclosureSEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 1 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 0 Underlying: Class B Subordinate Voting Shares · 3,082,933 shares Expires 2025-03-27 F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021. F2 · price: Not applicable. F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 1,259,035 | Not disclosed Strike: $0.16 | Not disclosed |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 24 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 1,259,035 Underlying: Class B Subordinate Voting Shares · 1,259,035 shares Expires 2026-01-11 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F9 · kind: Warrant was issued pursuant to the Third Restatement. See also footnote (1). F4 · price: Not applicable. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 3,214 | Not disclosed Strike: $1.17 | Not disclosed |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 23 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 22,500 Underlying: Class B Subordinate Voting Shares · 25,714 shares Expires 2022-11-27 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 11,127 | Not disclosed Strike: $1.01 | Not disclosed |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 22 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 77,884 Underlying: Class B Subordinate Voting Shares · 89,011 shares Expires 2022-11-27 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 2,572 | Not disclosed Strike: $3.65 | Not disclosed |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 21 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 18,004 Underlying: Class B Subordinate Voting Shares · 20,576 shares Expires 2022-07-12 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 8,903 | Not disclosed Strike: $3.16 | Not disclosed |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 20 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 62,322 Underlying: Class B Subordinate Voting Shares · 71,225 shares Expires 2022-07-12 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 8,741 | Not disclosed Strike: $4.29 | Not disclosed |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 19 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 61,189 Underlying: Class B Subordinate Voting Shares · 69,930 shares Expires 2022-05-22 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 30,259 | Not disclosed Strike: $3.72 | Not disclosed |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 18 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 211,807 Underlying: Class B Subordinate Voting Shares · 242,066 shares Expires 2022-05-22 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 3,986,944 | Not disclosed Strike: $0.16 | Not disclosed |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 17 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 3,986,944 Underlying: Class B Subordinate Voting Shares · 3,986,944 shares Expires 2026-01-11 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F9 · kind: Warrant was issued pursuant to the Third Restatement. See also footnote (1). F4 · price: Not applicable. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 10,178 | Not disclosed Strike: $1.17 | Not disclosed |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 16 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 71,250 Underlying: Class B Subordinate Voting Shares · 81,428 shares Expires 2022-11-27 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 35,234 | Not disclosed Strike: $1.01 | Not disclosed |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 15 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 246,633 Underlying: Class B Subordinate Voting Shares · 281,867 shares Expires 2022-11-27 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 8,145 | Not disclosed Strike: $3.65 | Not disclosed |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 14 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 57,013 Underlying: Class B Subordinate Voting Shares · 65,158 shares Expires 2022-07-12 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 28,193 | Not disclosed Strike: $3.16 | Not disclosed |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 13 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 197,353 Underlying: Class B Subordinate Voting Shares · 225,546 shares Expires 2022-07-12 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 27,680 | Not disclosed Strike: $4.29 | Not disclosed |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 12 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 193,765 Underlying: Class B Subordinate Voting Shares · 221,445 shares Expires 2022-05-22 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherWarrant · Derivative | 95,817 | Not disclosed Strike: $3.72 | Not disclosed |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 11 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: 670,724 Underlying: Class B Subordinate Voting Shares · 766,541 shares Expires 2022-05-22 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherSenior Secured Convertible Note · Derivative | Not disclosed | Not disclosed Strike: $0.17 | $1,403,716.39 |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 10 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: Not disclosed Underlying: Class B Subordinate Voting Shares · 8,257,155 shares Expires 2022-04-23 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F7 · kind: This Note may be deemed issued for the purpose of Section 16 pursuant to the Third Restatement upon amendment of the conversion price of the original Notes. See also footnotes (1) and (2). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherSenior Secured Convertible Note · Derivative | Not disclosed | Not disclosed Strike: $0.78 | $92,528.65 |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 9 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 0 Underlying: Class B Subordinate Voting Shares · 115,647 shares Expires 2022-04-23 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherSenior Secured Convertible Note · Derivative | Not disclosed | Not disclosed Strike: $1.28 | $174,678.90 |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 8 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 0 Underlying: Class B Subordinate Voting Shares · 132,700 shares Expires 2022-04-23 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherSenior Secured Convertible Note · Derivative | Not disclosed | Not disclosed Strike: $2.17 | $238,955.99 |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 7 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 0 Underlying: Class B Subordinate Voting Shares · 107,077 shares Expires 2022-04-23 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherSenior Secured Convertible Note · Derivative | Not disclosed | Not disclosed Strike: $2.55 | $897,552.85 |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 6 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD. Disclosed balance after: 0 Underlying: Class B Subordinate Voting Shares · 341,847 shares Expires 2022-04-23 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
| January 11, 2021 Filed Apr 29, 2022 20:42 UTC | MedMen Enterprises, Inc. MMNFF · Entity 94628 | OtherSenior Secured Convertible Note · Derivative | Not disclosed | Not disclosed Strike: $0.17 | $4,445,120.46 |
DisclosureSEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 5 PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner Kamen Efrem · CIK 0001789193 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pura Vida Master Fund, LTD. Disclosed balance after: Not disclosed Underlying: Class B Subordinate Voting Shares · 26,147,767 shares Expires 2022-04-23 F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion. F7 · kind: This Note may be deemed issued for the purpose of Section 16 pursuant to the Third Restatement upon amendment of the conversion price of the original Notes. See also footnotes (1) and (2). F4 · price: Not applicable. F3 · derivative.exercise_date: Currently exercisable as of Reporting Date. F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP. F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.